跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TEICOPLANIN SXP teicoplanin 400 mg powder for injection with diluent ampoule - TGA Drug Approval Details
Approvals
/
TGA
/
TEICOPLANIN SXP teicoplanin 400 mg powder for injection with diluent ampoule
Approved
STANDARD
TEICOPLANIN SXP teicoplanin 400 mg powder for injection with diluent ampoule
Southern Cross Pharma Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
14ea5bbb4f78d60a
Company
Southern Cross Pharma Pty Ltd
Type
Standard
Approval Details
Approval Id
14ea5bbb4f78d60a
Product Name
TEICOPLANIN SXP teicoplanin 400 mg powder for injection with diluent ampoule
Artg Id
259192
Artg Name
TEICOPLANIN SXP teicoplanin 400 mg powder for injection with diluent ampoule
Sponsor
Southern Cross Pharma Pty Ltd
Company Detail Path
/organization/southern-cross-pharma-pty-ltd
Artg Date
2017-06-07
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
14ea5bbb4f78d60a
Type
Standard
Back to TGA Approvals
